Assisted reproductive technology in SLE and APS Academic Article uri icon

Overview

MeSH Major

  • Antiphospholipid Syndrome
  • Lupus Erythematosus, Systemic
  • Reproductive Techniques, Assisted

abstract

  • Assisted reproductive technology (ART) procedures, which include in┬ávitro fertilization (IVF), are performed frequently and may be considered for patients with systemic lupus erythematosus and antiphospholipid syndrome. These procedures do not appear to increase the risk of disease flare or thrombosis in these patients. In addition, the presence of antiphospholipid antibodies (aPL) does not independently predict the outcome of IVF pregnancies. As with pregnancies that are achieved naturally, candidates for ART should have quiescent disease for at least 6 months prior to attempting pregnancy for the best possible outcome for mother and child.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1177/0961203314527370

PubMed ID

  • 25228714

Additional Document Info

start page

  • 1239

end page

  • 41

volume

  • 23

number

  • 12